Leveraging epigenetics to enhance the efficacy of immunotherapy.
Leveraging epigenetics to enhance the efficacy of immunotherapy.
复制标题
DOI:
10.1186/s13148-021-01100-x
复制
发表时间:
2021-05-17
影响因子:
5.7
通讯作者:
Bennett RL
中科院分区:
文献类型:
--
作者:
Licht JD;Bennett RL
Epigenetic mechanisms regulate chromatin accessibility patterns that govern interaction of transcription machinery with genes and their cis-regulatory elements. Mutations that affect epigenetic mechanisms are common in cancer. Because epigenetic modifications are reversible many anticancer strategies targeting these mechanisms are currently under development and in clinical trials. Here we review evidence suggesting that epigenetic therapeutics can deactivate immunosuppressive gene expression or reprogram tumor cells to activate antigen presentation mechanisms. In addition, the dysregulation of epigenetic mechanisms commonly observed in cancer may alter the immunogenicity of tumor cells and effectiveness of immunotherapies. Therapeutics targeting epigenetic mechanisms may be helpful to counter immune evasion and improve the effectiveness of immunotherapies.
登录
查看更多内容
影响因子:
5.2
作者:
Di Martino MT;Riillo C;Scionti F;Grillone K;Polerà N;Caracciolo D;Arbitrio M;Tagliaferri P;Tassone P
通讯作者:
Tassone P
影响因子:
10.3
作者:
Cortez, Maria Angelica;Ivan, Cristina;Welsh, James W.
通讯作者:
Welsh, James W.
影响因子:
64.5
作者:
Ghoneim HE;Fan Y;Moustaki A;Abdelsamed HA;Dash P;Dogra P;Carter R;Awad W;Neale G;Thomas PG;Youngblood B
通讯作者:
Youngblood B
影响因子:
9
作者:
Colangelo T;Polcaro G;Ziccardi P;Pucci B;Muccillo L;Galgani M;Fucci A;Milone MR;Budillon A;Santopaolo M;Votino C;Pancione M;Piepoli A;Mazzoccoli G;Binaschi M;Bigioni M;Maggi CA;Fassan M;Laudanna C;Matarese G;Sabatino L;Colantuoni V
通讯作者:
Colantuoni V
影响因子:
8.8
作者:
Chatterjee, Annesha;Jana, Samir;Bhattacharyya, Arindam
通讯作者:
Bhattacharyya, Arindam